Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
Jorge Soliz, Edith M. Schneider Gasser, Christian Arias‐Reyes, Fernanda Aliaga‐Raduán, Liliana Poma-Machicao, Gustavo Zubieta‐Calleja, Werner I. Furuya, Pedro Trevizan‐Baú, Rishi R. Dhingra, Mathias Dutschmann
Topics & Concepts
MedicineErythropoietinHypoxemiaIntensive care medicineHypoxia (environmental)Respiratory systemContext (archaeology)RhinovirusImmunologyInternal medicineBiologyPaleontologyOrganic chemistryOxygenChemistryErythropoietin and Anemia TreatmentCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19